- Supported exchanges /
- AU /
- OCC.AU
Orthocell Ltd (OCC AU) stock market data APIs
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union. The company offers Ortho-ATI, a cell therapy for treatment of chronic tendon injuries; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental procedure; Remplir, a collagen scaffold used in peripheral nerve repair; and Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.
Orthocell Ltd Financial Data Overview
| 0.45 | |
| 0.455 | |
| - | |
| 0.4575 | |
| 0.445 | |
| 0.322-0.48 | |
| 95 358 K | |
| 210 M | |
| 5 315 K | |
| 1.16 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Orthocell Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 5 315 K
- EBITDA -10 909 807
- Earnings Per Share -0.04
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Orthocell Ltd Earnings via APIs
- Latest Release 2024-08-30
- EPS/Forecast NaN
Get Orthocell Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
